Breast Cancer Vaccine
HER2/neu peptide induces epitope spreading in early stage breast cancer
Published in Women's Health Weekly, May 22nd, 2006
According to recent research from the United States, "We are conducting clinical vaccine trials with the HER2/neu peptide, E75, in patients with breast cancer. The purpose of this study was to demonstrate clonal expansion of E75-specific CD8+ T cells and to identify intra- and inter-antigenic epitope spreading. Pre-and post-vaccination peripheral blood leukocyte samples (24 node-positive [NP] and 20 node-negative [NN]) from 44 vaccinated patients were analyzed."
"HLA-A2:Ig dimer molecules were loaded with the HER2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast cancer incidence may be associated with larger bra cup size in premenopausal women - Cardiovascular Disease
Analysis of heart failure treatments reveals gaps in care may not be gender-related - Cardiovascular Disease
Heart disease in women with polycystic ovary syndrome may be linked to other risk factors - Cardiovascular Disease
Lipid levels are improved in postmenopausal women with regular consumption of red wine - Fitness & Wellness
Gender difference in sports achievement may be related to exercise frequency - Anesthesia
New research from the United Kingdom and Brazil in the area of anesthesia detailed - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
